• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年医疗保险优势计划对耳鼻喉科手术的预先授权要求

Medicare Advantage Prior Authorization Requirements for Otolaryngologic Procedures in 2021.

作者信息

Miller Lauren E, Miller Ashley L, Rocco James W, Rathi Vinay K

机构信息

Department of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA.

Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA.

出版信息

Otolaryngol Head Neck Surg. 2024 Nov;171(5):1601-1604. doi: 10.1002/ohn.931. Epub 2024 Aug 5.

DOI:10.1002/ohn.931
PMID:39101347
Abstract

Little is known about the extent of prior authorization requirements in otolaryngology. We performed a secondary analysis of data comparing prior authorization (PA) policies across 5 major Medicare Advantage insurers to estimate the counterfactual proportion of 2021 Medicare Part B fee-for-service spending and utilization for commonly performed otolaryngologic procedures that would have required PA. The counterfactual proportion of spending (range: 20.4%-27.6%) and utilization (range: 1.8%-4.5%) requiring PA was relatively consistent across insurers and largely attributable to rhinologic procedures. However, PA requirements for specific services varied widely among insurers. Among the 70 (of 196; 35.7%) services subject to PA by any insurer, nearly half were subject to PA by a single insurer (n = 34; 48.6%). Only 10 (14.3%) services were subject to PA by 4 (n = 6; 8.6%) or 5 (n = 4; 5.7%) insurers. These discrepancies illustrate the challenges of navigating discordant insurer policies for otolaryngologists and raise concerns about the validity of certain PA requirements.

摘要

关于耳鼻喉科事先授权要求的程度,人们了解甚少。我们对数据进行了二次分析,比较了5家主要医疗保险优势保险公司的事先授权(PA)政策,以估计2021年医疗保险B部分按服务收费支出和常见耳鼻喉科手术使用情况中需要事先授权的反事实比例。各保险公司之间,需要事先授权的支出反事实比例(范围:20.4%-27.6%)和使用情况反事实比例(范围:1.8%-4.5%)相对一致,且在很大程度上归因于鼻科手术。然而,各保险公司对特定服务的事先授权要求差异很大。在任何一家保险公司要求事先授权的196项服务中的70项(35.7%)中,近一半仅由一家保险公司要求事先授权(n = 34;48.6%)。只有10项(14.3%)服务由4家(n = 6;8.6%)或5家(n = 4;5.7%)保险公司要求事先授权。这些差异说明了耳鼻喉科医生在应对不一致的保险公司政策时面临的挑战,并引发了对某些事先授权要求有效性的担忧。

相似文献

1
Medicare Advantage Prior Authorization Requirements for Otolaryngologic Procedures in 2021.2021年医疗保险优势计划对耳鼻喉科手术的预先授权要求
Otolaryngol Head Neck Surg. 2024 Nov;171(5):1601-1604. doi: 10.1002/ohn.931. Epub 2024 Aug 5.
2
Comparison of prior authorization across insurers: cross sectional evidence from Medicare Advantage.比较不同保险公司的预先授权:来自 Medicare Advantage 的横断面证据。
BMJ. 2024 Mar 7;384:e077797. doi: 10.1136/bmj-2023-077797.
3
Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B.测量预先授权政策的范围:将私人保险公司的规定应用于医疗保险 B 部分。
JAMA Health Forum. 2021 May 28;2(5):e210859. doi: 10.1001/jamahealthforum.2021.0859. eCollection 2021 May.
4
Medicare Advantage coverage restrictions for the costliest physician-administered drugs.医疗保险优势计划对最昂贵的医师管理药物的覆盖范围限制。
Am J Manag Care. 2022 Jul 1;28(7):e255-e262. doi: 10.37765/ajmc.2022.89184.
5
The extent and growth of prior authorization in Medicare Advantage.医疗保险优势计划中预先授权的范围和增长。
Am J Manag Care. 2024 Mar 1;30(3):e85-e92. doi: 10.37765/ajmc.2024.89519.
6
Medicare Advantage Has Become Notorious for Prior Authorization-CMS and Lawmakers Are Taking Action.医疗保险优势计划因事先授权而声名狼藉——医疗保险和医疗补助服务中心及立法者正在采取行动。
JAMA. 2024 Sep 24;332(12):948-951. doi: 10.1001/jama.2024.13383.
7
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction.心力衰竭伴射血分数降低患者在医疗保险和商业计划中使用沙库巴曲缬沙坦的预先授权、共同支付和利用情况。
Circ Cardiovasc Qual Outcomes. 2021 Sep;14(9):e007665. doi: 10.1161/CIRCOUTCOMES.120.007665. Epub 2021 Sep 1.
8
2020 CMS prior authorization for hospital outpatient departments: Associated surgical volume impact.2020 年 CMS 对医院门诊部门的预先授权:相关手术量的影响。
Surgery. 2024 Nov;176(5):1412-1417. doi: 10.1016/j.surg.2024.07.010. Epub 2024 Aug 10.
9
Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.取消药物辅助治疗的事先授权:在医疗保险优势人群中对阿片类药物使用的影响及政策意义。
J Manag Care Spec Pharm. 2021 May;27(5):596-606. doi: 10.18553/jmcp.2021.27.5.596.
10
Rule Tackles Medicare Advantage Marketing, Prior Authorization.规则应对医疗保险优势营销、预先授权。
JAMA. 2023 May 9;329(18):1543. doi: 10.1001/jama.2023.6288.

引用本文的文献

1
Financial Impact of Medicare Payment Reform for E/M Visits on Compensation for Otolaryngologic Procedures in 2023.2023年医疗保险对门诊医疗服务支付改革对耳鼻喉科手术补偿的财务影响。
Otolaryngol Head Neck Surg. 2025 Apr;172(4):1281-1285. doi: 10.1002/ohn.1146. Epub 2025 Jan 26.